Publisher
Springer Science and Business Media LLC
Reference12 articles.
1. Parker, C. et al. Alpha emitter Radium-223 and survival in metastatic prostate cancer. N Engl J Med 369, 213–223 (2013).
2. Harrison, M. R., Wong, T. Z., Armstrong, A. J. & George, D. J. Radium-223 chloride: a potential new treatment for castration-resistant prostate cancer with metastatic bone disease. Cancer Manag. Res. 5, 1–14 (2013).
3. Bodei, L. et al. European Association of Nuclear Medicine (EANM). EANM procedure guideline for treatment of refractory metastatic bone pain. Eur. J. Nucl. Med. Mol. Imaging 35, 1934–1940 (2008).
4. Pandit-Taskar, N., Larson, S. M. & Carrasquillo, J. A. Bone-Seeking radiopharmaceuticals for treatment of osseous metastases, part 1: α Therapy with 223Ra-dichloride. J. Nucl. Med. 55, 268–274 (2014).
5. UNSCEAR, United Nations Scientific committee on the Effects of Atomic Radiation. Ionizing Radiation: Sources and biological effects. United Nations, New York. Annex BD (1982).
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献